Cancer Breakthroughs, Diabetes Drugs, and DTC Pharma

Kilder

• Statnews: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment - statnews.com
• statnews.com: CMS proposes rolling back breakthrough device payment flexibilities | STAT - statnews.com
• medscape.com: Intensive Lifestyle Intervention Boosts QOL in Obesity - Medscape
• news.google.com: Intensive Lifestyle Intervention Boosts QOL in Obesity - Medscape
• healio.com: Foundayo confers noninferior CV risk vs. insulin glargine for adults with type 2 diabetes - Healio
• news.google.com: Foundayo confers noninferior CV risk vs. insulin glargine for adults with type 2 diabetes - Healio
• nejm.org: Asundexian for Noncardioembolic Ischemic Stroke - NEJM
• thepharmaletter.com: Bayer's Phase III asundexian stroke study published in NEJM - The Pharma Letter
• Healthday: Cough Drops From Several Brands Being Recalled, FDA Says - HealthDay
• news.google.com: Cough drops from several brands being recalled, FDA says - Medical Xpress
• msn.com: 5 cough drop brands have been recalled due to manufacturing concerns, FDA says. See the full list - MSN
• Fiercehealthcare: DiMe leads effort to create standards for cash-pay drug models - Fierce Healthcare
• fiercehealthcare.com: DiMe leads effort to create standards for cash-pay drug models - Fierce Healthcare
• wikimedia: Photo by Staff of US Senate and/or Senator Ron Johnson / Wikimedia Commons / Public domain

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.